BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company […]
Category Archives: Pr Newswire
Pr Newswire
CORRECTION — Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)
17
Jul
Jul
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change to “infusion” that was made in the first sentence and decreased neutrophils to 92% that was made in the sixth paragraph. The corrected release follows: LOUISVILLE, Ky., July 16, 2024 (GLOBE NEWSWIRE) — Onco360®, the […]
Pr Newswire
ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
17
Jul
Jul
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients with mCRPC ORIC entered into clinical trial collaboration and supply agreements with Bayer and Johnson & Johnson SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Calif., July 16, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: […]
Pr Newswire
Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
17
Jul
Jul
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced today that it received written notification from The Nasdaq Stock Market LLC (“Nasdaq”) that it has granted the Company’s request for […]
Seasoned global business executive, Chris Jurasek, joins CUBE as Non-Exec Chair, reflecting CUBE’s transformational growth trajectory Experienced tech finance professional and diversity champion, Emma Brown, will join CUBE as Chief Financial Officer Stéphane Besson continues as Non-Exec Director having played a pivotal role in supporting CUBE’s acquisitions to date in 2024 LONDON, July 17, 2024 /PRNewswire/ — […]
Comprehensive Coaching Platform Offers Elite Training so Realty ONE Group Professionals can Achieve Greater Success Faster LAGUNA NIGUEL, Calif., July 17, 2024 /PRNewswire/ — Realty ONE Group International, a modern, purpose-driven lifestyle brand and ONE of the fastest growing franchisors in the world, is announcing the launch of ONE Coaching, ONE of the most comprehensive coaching […]
BAYTOWN, Texas, July 17, 2024 /PRNewswire/ — Capital Development Partners has announced that it has delivered an 800,405 SF speculative rail service building for immediate occupancy within the Cedar Port Industrial Park in Baytown, Texas. Cedar Port Logistics Center Building II will be able to serve both rail service users and non-rail service users with direct […]
Aramco and Air Products Qudra join forces to develop lower-carbon hydrogen production business Companies agree shared ownership of Jubail firm, with plans to supply hydrogen through a pipeline network in Saudi Arabia’s Eastern Province Agreement aims to support growth of Aramco’s New Energies portfolio DHAHRAN, Saudi Arabia, July 17, 2024 /PRNewswire/ — Aramco, one of […]
The best time of year to buy portable generators for summer camping and hurricane preparedness. LAS VEGAS, July 17, 2024 /PRNewswire/ — As Amazon Prime Day 2024 approaches, BLUETTI, a leading provider of eco-friendly power solutions, is joining the Prime Day Sale with unbeatable deals on various portable solar generators from July 16-21 on Bluetti Official and […]
Pr Newswire
Celldex Therapeutics Initiates Global Phase 3 Program for Barzolvolimab in Patients with Chronic Spontaneous Urticaria
16
Jul
Jul
– EMBARQ-CSU1 and EMBARQ-CSU 2 will enroll more than 1800 patients suffering from CSU –– Studies include both biologic naïve and experienced patients – HAMPTON, N.J., July 16, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today the initiation of its global Phase 3 program, consisting of two Phase 3 trials (EMBARQ-CSU1 and EMBARQ-CSU2) […]